1. Home
  2. Labeler Index
  3. Direct Rx
  4. 61919-107
  5. NDC Package Code: 61919-107-30 Verapamil Hydrochloride

NDC Package 61919-107-30 Verapamil Hydrochloride

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
61919-107-30
Package Description:
30 TABLET in 1 BOTTLE
Product Code:
61919-107
Proprietary Name:
Verapamil Hydrochloride
Usage Information:
Verapamil hydrochloride tablets USP are indicated for the treatment of the following:Angina1.Angina at rest including: -Vasospastic (Prinzmetal's variant) angina -Unstable (crescendo, pre-infarction) angina2.Chronic stable angina (classic effort-associated angina)Arrhythmias1.In association with digitalis for the control of ventricular rate at rest and during stress in patients with chronic atrial flutter and/or atrial fibrillation (see WARNINGS: ACCESSORY BYPASS TRACT )2.Prophylaxis of repetitive paroxysmal supraventricular tachycardiaEssential hypertensionVerapamil hydrochloride is indicated for the treatment of hypertension, to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes, including this drug.Control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. Many patients will require more than one drug to achieve blood pressure goals. For specific advice on goals and management, see published guidelines, such as those of the National High Blood Pressure Education Program's Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC).Numerous antihypertensive drugs, from a variety of pharmacologic classes and with different mechanisms of action, have been shown in randomized controlled trials to reduce cardiovascular morbidity and mortality, and it can be concluded that it is blood pressure reduction, and not some other pharmacologic property of the drugs, that is largely responsible for those benefits. The largest and most consistent cardiovascular outcome benefit has been a reduction in the risk of stroke, but reductions in myocardial infarction and cardiovascular mortality also have been seen regularly.Elevated systolic or diastolic pressure causes increased cardiovascular risk, and the absolute risk increase per mmHg is greater at higher blood pressures, so that even modest reductions of severe hypertension can provide substantial benefit. Relative risk reduction from blood pressure reduction is similar across populations with varying absolute risk, so the absolute benefit is greater in patients who are at higher risk independent of their hypertension (for example, patients with diabetes or hyperlipidemia), and such patients would be expected to benefit from more aggressive treatment to a lower blood pressure goal.Some antihypertensive drugs have smaller blood pressure effects (as monotherapy) in black patients, and many antihypertensive drugs have additional approved indications and effects (e.g., on angina, heart failure, or diabetic kidney disease). These considerations may guide selection of therapy.
11-Digit NDC Billing Format:
61919010730
NDC to RxNorm Crosswalk:
  • RxCUI: 897666 - verapamil HCl 120 MG Oral Tablet
  • RxCUI: 897666 - verapamil hydrochloride 120 MG Oral Tablet
    • Labeler Name:
    Direct Rx
    Sample Package:
    No
    Start Marketing Date:
    03-15-2017
    Listing Expiration Date:
    12-31-2022
    Exclude Flag:
    I
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 61919-107-30?

    The NDC Packaged Code 61919-107-30 is assigned to a package of 30 tablet in 1 bottle of Verapamil Hydrochloride, labeled by Direct Rx. The product's dosage form is and is administered via form.

    Is NDC 61919-107 included in the NDC Directory?

    No, Verapamil Hydrochloride with product code 61919-107 is excluded from the NDC Directory because it's listing has been INACTIVATED by FDA. The product was first marketed by Direct Rx on March 15, 2017 and its listing in the NDC Directory is set to expire on December 31, 2022 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 61919-107-30?

    The 11-digit format is 61919010730. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-261919-107-305-4-261919-0107-30